Autres langues Axogen, Inc.

Actions

AXGN

US05463X1063

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq 22:00:00 05/10/2026			Varia. 5j.	Varia. 1 janv.
37,22 ^USD	-0,45%		-14,16%	+13,72%

01/10	Axogen, Inc. : Truist Securities persiste à l'achat	ZM
01/10	Axogen, Inc. (NasdaqCM:AXGN) a finalisé l’acquisition de BioCircuit Technologies, Inc.	CI

Autres langues

01/10	Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair
01/10	Axogen, Inc. completed its acquisition of BioCircuit Technologies, Inc.
10/09	Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Thursday Amid Producer Price Inflation Data Release
10/09	Axogen Prices $208.7 Million Public Offering
10/09	Axogen to Acquire BioCircuit Technologies for $200 Million
10/09	Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock
10/09	Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies
10/09	Axogen, Inc. agreed to acquire BioCircuit Technologies, Inc. for approximately $200 million.
01/09	Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference
26/08	U.S. research roundup- Intuit, MongoDB, Zscaler
12/08	Axogen Insider Sold Shares Worth $646,592, According to a Recent SEC Filing
12/08	Axogen Insider Sold Shares Worth $3,195,788, According to a Recent SEC Filing
29/07	Axogen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
29/07	Axogen, Inc. Raises Earnings Guidance for the Year 2026
29/07	Trace Biosciences Incorporated announced that it has received $16.234492 million in funding from Axogen, Inc.
29/07	Earnings Flash (AXGN) Axogen Reports Q2 Revenue $69.7M, vs. FactSet Est of $67.1M
29/07	(AXGN) Axogen Expects 2026 Revenue At Least $279M, vs. FactSet Est of $270.9M
29/07	Earnings Flash (AXGN) Axogen, Inc. Posts Q2 Adjusted EPS $0.12 per Share, vs. FactSet Est of $0.12
29/07	AxoGen: Q2 Earnings Snapshot
29/07	Axogen, Inc. Reports Second Quarter 2026 Financial Results
27/07	Trace Biosciences Incorporated announced that it expects to receive funding
20/07	Neuronetics Names Nir Naor as CFO
15/07	Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026
13/07	Bosch in $225 Million Agreement With U.S. Department of Commerce for Roseville Facility
13/07	Bosch sichert sich 225-Millionen-Förderung für US-Chipwerk